drugset / Trial / NCT02244229

Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patients

NCT02244229

Phase 4 Completed 403 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

Study to evaluate the therapeutic effect of tamsulosin and finasteride in symptomatic BPH patients, two medications indicated in BPH belonging to two different pharmacological classes, as evaluated from the point of view of patient's perception of his pathological condition and of the impact of the disease on general health and quality of life

Timeline

Start
1998-04
Primary completion
2000-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Finasteride Small molecule
Subject Tamsulosin Other / unclassified